Llwytho...
Clinical pharmacology strategies in supporting drug development and approval of antibody–drug conjugates in oncology
Antibody–drug conjugates (ADCs) are important molecular entities in the treatment of cancer. These conjugates combine the target specificity of monoclonal antibodies with the potent anti-cancer activity of small-molecule therapeutics. The complex structure of ADCs poses unique challenges to characte...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cancer Chemother Pharmacol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer Berlin Heidelberg
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8110483/ https://ncbi.nlm.nih.gov/pubmed/33792763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-021-04250-0 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|